Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV

NCT05258136 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

PTLD
CAEBV
HLH

Interventions

DRUG: low-dose CD20 monoclonal antibody injection

Sponsor

Beijing Friendship Hospital